产品中心 抗体 其他一抗

所有图片(1/1)

CD8α Recombinant Rat mAb (S-353-45)

T-cell surface glycoprotein CD8 alpha chain,T-cell surface glycoprotein Lyt-2,Lyt-2,Lyt2

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B0670
规格
数量
收藏 分享

产品介绍 FAQs 评论(0)

产品规格
  • 宿主来源

    Rat
  • 抗原名称

    CD8α
  • 分子别名

    T-cell surface glycoprotein CD8 alpha chain, T-cell surface glycoprotein Lyt-2, Lyt-2, Lyt2
  • 免疫原

    Recombinant Protein
  • 细胞定位

    Cell membrane
  • Accession

    P01731
  • 克隆号

    S-353-45
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG1,λ
  • 反应种属 ?

    Ms
  • 纯化方式

    Protein G
  • 浓度

    0.2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20°C as supplied

  • 应用

    FCM

  • 稀释度

    应用 稀释度
    FCM 1:2000
背景介绍
  • CD8a, also known as CD8α, is a molecular marker on the surface of T lymphocytes. It belongs to the family of leukocyte differentiation antigens and is primarily expressed on the surface of cytotoxic T lymphocytes (CTLs). CD8a plays a crucial role in immune responses related to cytotoxicity and local inflammation. It has the ability to bind to MHC class I molecules. The expression level of CD8 molecules undergoes changes during various stages of T cell differentiation, development, and in response to T cell stimuli. Additionally, CD8a is closely associated with autoimmune monitoring, humoral immune responses, and transplant reactions. For instance, CD8a can serve as a monitoring indicator for certain autoimmune diseases and plays a significant role in immunotherapy for anti-tumor and anti-viral treatments.

  • 流式分析

    • Flow cytometric analysis of C57BL/6 mouse splenocytes labeling CD8α at 1/2000 (0.01 μg) dilution / (Right panel) compared with a Rat IgG, Isotype Control / (Left panel). Goat Anti - Rat IgG Alexa Fluor® 488 was used as the secondary antibody. Then cells were stained with CD4 - Alexa Fluor® 647 separately. Gated on total viable cells.

FAQs

斯达特公司的抗体,可以回收利用几次?

我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定

评论(0)